Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes

Burge, 1998, A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus, JAMA, 279, 137, 10.1001/jama.279.2.137 Garber, 1976, The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man, J Clin Invest, 58, 7, 10.1172/JCI108460 Mitrakou, 1991, Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction, Am J Physiol, 260, E67 Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patient with poorly controlled diabetes and nondiabetics, N Engl J Med, 318, 1487, 10.1056/NEJM198806093182302 The Committee on Exercise Testing, 1997, Guidelines for exercise testing: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 30, 260 American Diabetes Association, 1977, Nutrition recommendations and principles for people with diabetes mellitus, Diabetes Care, 20, S14 Clutter, 1980, Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man, J Clin Invest, 66, 94, 10.1172/JCI109840 Golden, 1980 Ensinck, 1983, Immunoassays for glucagon, 203 Shah, 1985, External and internal standards in the single isotope derivative (radioenzymatic) assay of plasma norepinephrine and epinephrine in normal humans and persons with diabetes mellitus or chronic renal failure, J Lab Clin Med, 106, 624 Argound, 1987, Underestimation of hepatic glucose production by radioactive and stable tracers, Am J Physiol, 252, E606 Tserng, 1983, Calculation of substrate turnover rate in stable isotope tracer studies, Am J Physiol, 245, E308 Steele, 1956, Measurement of size and turnover rate of body glucose pool by the isotope dilution methods, Am J Physiol, 187, 15, 10.1152/ajplegacy.1956.187.1.15 Radziuk, 1985, The metabolic clearance rate of glucose: Measurement and meaning, Diabetologia, 28, 315, 10.1007/BF00283136 Meneilly, 1994, Altered responses to hypoglycemia of healthy elderly people, J Clin Endocrinol Metab, 78, 1341, 10.1210/jc.78.6.1341 Marker, 1992, Attenuated glucose recovery from hypoglycemia in the elderly, Diabetes, 41, 671, 10.2337/diabetes.41.6.671 Boden, 1983, Counterregulatory hormone release and glucose recovery after hypoglycemia in non—insulin-dependent diabetic patients, Diabetes, 32, 1055, 10.2337/diabetes.32.11.1055 Meneilly, 1994, Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes, Diabetes, 43, 403, 10.2337/diabetes.43.3.403 Bolli, 1984, Defective glucose counterreglation after subcutaneous insulin in non—insulin-dependent diabetes mellitus, J Clin Invest, 73, 1532, 10.1172/JCI111359 Cryer, 1995, Diseases of the sympathochromaffin system, 713 Shammon, 1980, Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics, Diabetes, 29, 284, 10.2337/diab.29.4.284 Berk, 1985, Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin, J Clin Invest, 75, 1842, 10.1172/JCI111898 Rizza, 1979, Differential effects of physiological concentrations of epinephrine on glucose production and disposal, Am J Physiol, 237, E356 Stratton, 1985, Hemodynamic effects of epinephrine: Concentration-effect study in humans, J Appl Physiol, 58, 1199, 10.1152/jappl.1985.58.4.1199 Rizza, 1980, Adrenergic mechanisms for the effect of epinephrine on glucose production and clearance in man, J Clin Invest, 65, 682, 10.1172/JCI109714 Bergman, 1997, New concepts in extracellular singling for insulin action: The single gateway hypothesis, Recent Prog Horm Res, 52, 359 Galster, 1981, Epinephrine plasma thresholds for lipolytic effects in man, J Clin Invest, 67, 1729, 10.1172/JCI110211